Chemical Structure
Inhibitor
2340 Citations
Dasatinib
BT-0014
Dasatinib is a dual BCR-ABL and Src family kinase inhibitor approved for chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive ALL.
Biological Activity
Inhibits BCR-ABL, Src, c-Kit, PDGFR, and Ephrin receptor tyrosine kinases.
Product Specifications
CAS Number302962-49-8
Molecular FormulaC22H26ClN7O2S
Molecular Weight488.01 g/mol
TargetBCR-ABL, Src
PathwayBCR-ABL Signaling
Disease AreaCancer
IC50/EC50/KdIC50: <1 nM (BCR-ABL)
Purity>99%
SolubilityDMSO: ≥25 mg/mL
Storage-20°C
SpeciesHuman
Available Sizes
| Size | Price | |
|---|---|---|
| 10 mg | $50.00 | |
| 50 mg | $175.00 |